Italia markets open in 3 hours 56 minutes

Dow Jones
39.908,00
+349,89(+0,88%)
Nasdaq
16.742,39
+231,21(+1,40%)
Nikkei 225
38.669,57
+283,84(+0,74%)
EUR/USD
1,0891
+0,0004(+0,03%)
Bitcoin EUR
60.628,82
+3.849,64(+6,78%)
CMC Crypto 200
1.389,71
+121,76(+9,60%)

NVCR Jan 2026 5.000 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

0,6000

0,0000

(0,00%)

In data: 11:13AM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in